ACR Congress Do Not Miss… ACR Convergence 2023 – Rheumatoid arthritis II – Clinical (therapeutic) 6 Nov 20236 Nov 2023 Stefan DinescuStefan is a rheumatology specialist and lecturer at the University of Medicine and Pharmacy Craiova (Romania). His main research interests include rheumatoid arthritis, spondyloarthritis and musculoskeletal ultrasound. Stefan is…
Rheumatoid arthritis II - therapeutic… [EULAR HL 2023] Rheumatoid Arthritis II- Clinical- Therapeutic 20 Jun 2023 Author: Lise Verhoef Cope et al. (OP0130) evaluated the feasibility, efficacy and acceptability of 52 weeks of abatacept compared to placebo in 213 individuals at risk of developing rheumatoid arthritis…
Rheumatoid arthritis II - therapeutic… Rheumatoid Arthritis II – Clinical (therapeutic) 29 May 202330 May 2023 Alessandro Giollo Alessandro Giollo currently serves as the lead of refractory arthritis, synovial biopsy and osteoporosis clinics at the Rheumatology Unit, University of Padova (Italy). His clinical work and research…
Rheumatoid arthritis II - therapeutic [ACR22] Rheumatoid Arthritis II – Clinical (Therapeutic) 29 Nov 20226 Dec 2022 Author: Daliya Pencheva Emery et al (L03) introduced the concept of stimulating human programmed cell death protein 1 (PD-1) as a new rheumatoid arthritis (RA) treatment. In a Phase 2a,…